Routine hepatitis B immunisation in India: cost-effectiveness assessment.

Simple item page
dc.contributor.authorMiller, M Aen_US
dc.contributor.authorKane, Men_US
dc.date.accessioned2000-04-06en_US
dc.date.accessioned2009-05-30T13:28:33Z
dc.date.available2000-04-06en_US
dc.date.available2009-05-30T13:28:33Z
dc.date.issued2000-04-06en_US
dc.description.abstractBased on World Bank guidelines, hepatitis B immunization would be an excellent public health investment, saving each life year for well below the per-capita gross domestic product. This would be one of the most cost-effective investments India could make in the field of health.en_US
dc.description.affiliationResearch Fogarty International Center NIH, Bethesda, MD 20892-2220, USA. millermark@who.chen_US
dc.identifier.citationMiller MA, Kane M. Routine hepatitis B immunisation in India: cost-effectiveness assessment. Indian Journal of Pediatrics. 2000 Apr; 67(4): 299-300en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/81723
dc.language.isoengen_US
dc.source.urihttps://medind.nic.in/icb/icbai.shtmlen_US
dc.subject.meshChilden_US
dc.subject.meshCost-Benefit Analysisen_US
dc.subject.meshHepatitis B Vaccines --economicsen_US
dc.subject.meshHumansen_US
dc.subject.meshImmunization Programsen_US
dc.subject.meshIndiaen_US
dc.titleRoutine hepatitis B immunisation in India: cost-effectiveness assessment.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Pediatrics